Dive in
We have our own point of view on the people, technologies, and conversations that will shape the future.
The enterprise AI landscape is being rewritten in real time. As pilots give way to production, we surveyed 600 U.S. enterprise IT decision-makers to reveal the emerging winners and losers.
At Menlo Ventures, we remain excited about the future of cybersecurity, particularly companies leading with AI innovation.
Numeric is the first company succeeding in building the financial graph that unifies disparate data silos, workflows, and subledgers.
Since announcing the Anthology Fund, we’ve received thousands of applications from pioneering founders. Here’s what we discovered about the next wave of AI-powered companies.
The battle for AI talent continues to heat up: Top AI/ML scientists and researchers are now commanding staggering compensation packages that far exceed those of traditional technical roles like software engineers.
Unlike previous generations of software that primarily addressed low-level, sequential tasks that could be robotically executed, new cognitive architectures enable AI agents to dynamically automate end-to-end processes.
With new building blocks like multi-step logic, external memory, and access to third-party tools and APIs, the next wave of agents is expanding the frontier of AI capabilities to enable end-to-end process automation.
The Anthology Fund is a $100 million initiative created through a partnership between Menlo Ventures and Anthropic to fuel the next generation of AI startups.
We are delighted to announce that Menlo Ventures is leading Kinetic’s $21 million Series B to support them on their journey to rethink smart car maintenance and repair.
C.C. joins us as a principal, focused on AI applications for consumer and enterprise and broader consumer tech.
Raph Parker is an advisor to companies on their $0 to $10 million ARR journey. Here are four of his most valuable GTM tips for navigating early-stage sales.
Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.
With supply chain companies increasingly recognizing the advantages of shared data and optimized workflows, a new era of collaboration is on the horizon.
Observe’s success in moving to the enterprise provides a playbook for both startups and enterprises on how to leverage GenAI to win together.